Clinical Studies

Alzheimer’s and Memory Loss Clinical Studies

Have you been diagnosed with Alzheimer’s ? Do you want to partner in the kind of research that can give your grandchildren greater access to more effective treatment options? Maybe you’d like to be a part of finding a cure?

We’re partnering with patients like you on groundbreaking research to help doctors and caregivers treat and care for those affected by Alzheimer’s disease today, as well as those who come after us.

We’d love to partner with you.

Do I qualify?

Each clinical study has its own set of criteria that a patient must meet in order to participate. The first step to find out if you or a loved one qualifies is to schedule a prescreen interview with one of our team members.

Types of Studies

What studies are available?

Below you’ll find the clinical trials that we’re currently enrolling patients in or will be soon.

View All Open Studies

“AACM” Alzheimer’s Prevention
If you're worried that your memory might start fading, then joining an Alzheimer's prevention study might be a great option for you. It might just...
“AHEAD” Alzheimer’s Prevention
If you're worried that your memory might start fading, then joining an Alzheimer's prevention study might be a great option for you. It might just...
“Prevención del Alzheimer “AHEAD
Si le preocupa que su memoria empiece a fallar, apuntarse a un estudio de prevención del Alzheimer puede ser una gran opción para usted. También...
“Cassava” Alzheimer’s Trial
This trial aims to determine if a new, twice-a-day, oral drug called simufilam is safe and effective in slowing the progression of Alzheimer's disease.
“CELIA” Alzheimer’s Trial
This study tests a new investigational medication for the treatment of Alzheimer's disease.  The drug is hoped to work by targeting and preventing the accumulation...
“ENVISION” Alzheimer’s Trial
This study tests the FDA-approved medication Aduhelm. The trial is designed to verify the drug's efficacy in reducing amyloid plaques and slowing the rate of...
“Merck” Early Alzheimer’s Disease Trial
In this trial, an investigational drug is used to target tau proteins to reduce or stop their spread and slow the progression of Alzheimer's disease.

Commitment to Your Care

Who will I be working with?

Participating in a clinical trial can feel intimidating at first. Put your mind at ease by getting to know some of our caring experts who’ll be working with you every step of the way.

Learn more about our Commitment to Care

Jeffrey Norton, MD
Medical Director, The Villages
Leading our research center in The Villages, Florida, Dr. Jeffrey Norton has more than 20 years of experience in anesthesiology and pain management and has served...
Edgardo J. Rivera, MD, FACEP
Medical Director, Winter Park
Leading our research center in Winter Park, Florida, Dr. Edgardo Rivera has served as Principal Investigator or Sub-Investigator on more than 40 clinical trials across...
Diana Balsalobre, MD
Principal Investigator
Dr. Diana Balsalobre is a Board-Certified Neurologist with over 22 years of clinical experience.  She completed her Internship and Neurology Residency in Jackson Memorial Hospital...
Mary Quarterman, MD
Principal Investigator
Dr. Mary Quarterman is an established and highly skilled physician with over 13 years of experience.  Dr. Quarterman received her medical degree from Florida State...
Ramon Rodriguez, MD
Principal Investigator
Dr. Ramon Rodriguez is a board certified Neurologist and highly experienced Principal Investigator. Dr. Rodriguez received his medical degree (M.D.) from the University of Puerto...
Alexander Smirnoff, MD
Principal Investigator
With 12 years of experience as Principal Investigator and Sub-Investigator, Dr. Alexander Smirnoff has led more than 50 clinical trials in neurodegenerative disorders.  Dr. Smirnoff...

Our Promise to You

What resources do you have for me?

We regularly share insights, tips, and new discoveries to provide you the latest on the diseases and chronic conditions you’re living with.

See all resources

The lesser-known problematic protein wreaking havoc on the brain: TDP-43
Scientists have linked the progression of Alzheimer’s to the buildup of certain kinds of protein in the brain, which malfunction and gum up communication between...
Could Drugs for Other Diseases Be the Answer to Treating Alzheimer’s?
Asthma drugs, cancer drugs, even obesity drugs, are all being explored for their potential in treating the pathology and symptoms of Alzheimer’s disease. Finding the...
Why Women Are More Likely to Develop Alzheimer’s
Research has established that women are twice as likely to develop Alzheimer’s, but despite study after study into this sex-based disparity in Alzheimer’s risk, scientists...
Managing Symptoms in the Later Stages of Alzheimer’s
Symptom management in Alzheimer’s helps people remain independent for longer. Alzheimer’s disease is a progressive neurodegenerative condition that affects more than one in every 9...
A Pill For Alzheimer’s? Alzheon Starts Clinical Trials
Charter Research is recruiting for a new Phase 3 trial for Alzheon’s new drug, which aims to be the first oral disease-modifying therapy for Alzheimer’s....
Simple Snack or ‘Superfood’? What We Know About Berries, Brain Health & Dementia Prevention
Berries aren’t just a delicious cereal topping or perfect midday snack: Every few months, news outlets and websites pick up on new research into the...

Sign up to receive new Alzheimers research and resources.

Let us come to you. Sign up for our newsletter, and we’ll send updates right to your inbox.

Your information

This field is for validation purposes and should be left unchanged.